Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Almujtama Alraida Medical Co's ROE % for the quarter that ended in Dec. 2025 was 6.14%. Almujtama Alraida Medical Co's PB Ratio for the quarter that ended in Dec. 2025 was 2.23.
Almujtama Alraida Medical Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 2.75%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almujtama Alraida Medical Co ROE % Adjusted to Book Value Chart
Almujtama Alraida Medical Co ROE % Adjusted to Book Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almujtama Alraida Medical Co ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Almujtama Alraida Medical Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 2.75% mean?
Almujtama Alraida Medical Co (SAU:9592) has a ROE % Adjusted to Book Value of 2.75% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Almujtama Alraida Medical Co and its competitors.
Is Almujtama Alraida Medical Co's ROE % Adjusted to Book Value too high?
Almujtama Alraida Medical Co's current ROE % Adjusted to Book Value is 2.75%. Overall, Almujtama Alraida Medical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Almujtama Alraida Medical Co's ROE % Adjusted to Book Value compare to competitors?
Almujtama Alraida Medical Co's ROE % Adjusted to Book Value of 2.75% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Almujtama Alraida Medical Co and its competitors. Almujtama Alraida Medical Co's current ROE % Adjusted to Book Value is 2.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almujtama Alraida Medical Co stock overvalued right now?
Almujtama Alraida Medical Co (SAU:9592) has a current ROE % Adjusted to Book Value of 2.75%. The current ROE % Adjusted to Book Value is 2.75%. Almujtama Alraida Medical Co's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Almujtama Alraida Medical Co (SAU:9592), the current ROE % Adjusted to Book Value is 2.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retailing pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia.
13GF Score
Get the complete analysis for SAU:9592
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9592 has been successfully added to your 
